Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 766 AL 780

Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease

Halawa OA, Gatchel JR, Amariglio RE, Rentz DM, Sperling RA, Johnson KA, Marshall GA; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2019 Jan 31;11(1):14. doi: 10.1186/s13195-019-0471-6.

Late-onset Alzheimer Disease

Rabinovici GD.

Continuum (Minneap Minn). 2019 Feb;25(1):14-33. doi: 10.1212/CON.0000000000000700.

Early-onset Alzheimer Disease and Its Variants

Mendez MF.

Continuum (Minneap Minn). 2019 Feb;25(1):34-51. doi: 10.1212/CON.0000000000000687.

Progression of logopenic aphasia to frontotemporal dementia in an amyloid β-negative and (18) F-THK-5351-positive patient

Takaya M, Ishii K, Kubota I, Shirakawa O.

Psychogeriatrics. 2019 Jul;19(4):399-401. doi: 10.1111/psyg.12396. Epub 2019 Feb 3.

Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study

de Mauleon A, Soto M, Ousset PJ, Nourhashemi F, Lepage B, Vellas B.

Int Psychogeriatr. 2019 Oct;31(10):1509-1516. doi: 10.1017/S1041610218001990.

Differences in Cognitive Impairment in Primary Age-Related Tauopathy Versus Alzheimer Disease

Besser LM, Mock C, Teylan MA, Hassenstab J, Kukull WA, Crary JF.

J Neuropathol Exp Neurol. 2019 Mar 1;78(3):219-228. doi: 10.1093/jnen/nly132.

Dementia in Down syndrome: unique insights for Alzheimer disease research

Lott IT, Head E.

Nat Rev Neurol. 2019 Mar;15(3):135-147. doi: 10.1038/s41582-018-0132-6.

The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: A systematic review and meta-analysis

Lin Y, Jiang WJ, Shan PY, Lu M, Wang T, Li RH, Zhang N, Ma L.

J Neurol Sci. 2019 Mar 15;398:184-191. doi: 10.1016/j.jns.2019.01.038. Epub 2019 Jan 24.

PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism

Altinoz MA, Ozpinar A.

Int Immunopharmacol. 2019 Apr;69:245-256. doi: 10.1016/j.intimp.2019.01.057. Epub 2019 Feb 8.

Auditory Brainstem Dysfunction, Non-Invasive Biomarkers for Early Diagnosis and Monitoring of Alzheimer's Disease in Young Urban Residents Exposed to Air Pollution

Mansour Y, Blackburn K, González-González LO, Calderón-Garcidueñas L, Kulesza RJ.

J Alzheimers Dis. 2019;67(4):1147-1155. doi: 10.3233/JAD-181186.

The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans

Stepler KE, Robinson RAS.

Adv Exp Med Biol. 2019;1118:1-28. doi: 10.1007/978-3-030-05542-4_1.

Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms

Takatori S, Wang W, Iguchi A, Tomita T.

Adv Exp Med Biol. 2019;1118:83-116. doi: 10.1007/978-3-030-05542-4_5.

Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis

Ruthirakuhan M, Lanctôt KL, Vieira D, Herrmann N.

J Clin Psychiatry. 2019 Jan 29;80(2):18r12617. doi: 10.4088/JCP.18r12617.

Young adult-onset, very slowly progressive cognitive decline with spastic paraparesis in Alzheimer's disease with cotton wool plaques due to a novel presenilin1 G417S mutation

Miki T, Yokota O, Haraguchi T, Ikeuchi T, Zhu B, Takenoshita S, Terada S, Yamada N.

Acta Neuropathol Commun. 2019 Feb 12;7(1):19. doi: 10.1186/s40478-019-0672-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias